Abstract
New York City—While an autoimmune disease of any type is a serious condition that is often difficult to treat, finding a cure for type 1 diabetes is particularly daunting because of the nature of the pancreas and its insulinproducing beta cells. “The pancreas is pathetic at regeneration,” said Douglas Melton, PhD, of the Harvard Stem Cell Institute at Harvard University, in Cambridge, Mass. Thus, finding a way to generate beta cells poses a difficult challenge for researchers. The promise and shortcomings of various options were discussed by Melton and others at the New York Stem Cell Foundation’s recent Translat ional Stem Cell Research Conference.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
